---
title: "WHO and ILO launch framework to track universal social protection for people with TB"
id: "who-0-3-new-who-ilo-framework-to-track-progress-towards-universal-social-protection"
canonical_url: "https://medichelpline.com/clinical-feed/who-0-3-new-who-ilo-framework-to-track-progress-towards-universal-social-protection"
content_type: "clinical_feed_article"
specialty: "Infectious Disease"
source_name: "World Health Organization"
source_url: "https://www.who.int/news/item/21-10-2026-new-who-ilo-framework-to-track-progress-towards-universal-social-protection-inclusive-of-people-with-tb"
published_at: "2026-10-21T12:00:00.000Z"
evidence_level: "Departmental update"
license: "CC-BY-NC-4.0 / Informational Use"
---
# WHO and ILO launch framework to track universal social protection for people with TB
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/who-0-3-new-who-ilo-framework-to-track-progress-towards-universal-social-protection
- **Specialty:** [Infectious Disease](https://medichelpline.com/clinical-feed/infectious-disease.md)
- **Primary Source:** World Health Organization
- **Source URL:** [Original Journal Publication](https://www.who.int/news/item/21-10-2026-new-who-ilo-framework-to-track-progress-towards-universal-social-protection-inclusive-of-people-with-tb)
- **Published At:** 2026-10-21T12:00:00.000Z
- **Evidence Rating:** Departmental update
## Executive GIST (TL;DR)
- The World Health Organization and the International Labour Organization released a new framework to track progress towards **universal social protection** that explicitly includes people affected by **Tuberculosis**. - The source announced the framework as a joint WHO–ILO effort; the news item framed the document as a monitoring and tracking tool for policy progress. - The WHO item stated the framework’s purpose is to measure progress towards inclusion in social protection systems for people with TB, but it did not provide indicator lists or measurement methodology in the text available. - The announcement named WHO and ILO as the organizations involved; the source did not list additional implementing partners or country-level adopters. - The news release did not report timelines, target dates, or phased roll-out plans for the framework’s deployment or country reporting. - The source did not include sample country data, baseline metrics, or examples of social protection schemes that would be classified as compliant under the framework. - The WHO post did not provide operational details about data sources, data collection frequency, or expected reporting mechanisms for national authorities. - The text did not describe resourcing, funding commitments, or technical assistance to support countries in adopting the framework. - The item raised practical questions for implementers—on indicators, definitions of coverage, and monitoring capacity—because those specifics were not presented in the available source material. - Readers wanting operational detail will need to consult the full framework document or follow-up WHO/ILO communications; the news item itself served as an announcement rather than a methods publication.
## Clinical Analysis & Structured Key Points
[Skip to main content](https://www.who.int/news/item/21-10-2026-new-who-ilo-framework-to-track-progress-towards-universal-social-protection-inclusive-of-people-with-tb#content) * [ World Health Organization ](https://www.who.int/) [Global](https://www.who.int/) * [Regions](https://www.who.int/news/item/21-10-2026-new-who-ilo-framework-to-track-progress-towards-universal-social-protection-inclusive-of-people-with-tb) World Health Organization WHO Regional websites * [ Africa ](https://www.afro.who.int/) * [ Americas ](https://www.paho.org/en) * [ South-East Asia ](https://www.who.int/southeastasia) * [ Europe ](https://www.who.int/europe/) * [ Eastern Mediterranean ](http://www.emro.who.int/index.html) * [ Western Pacific ](https://www.who.int/westernpacific/) When autocomplete results are available use up and down arrows to review and enter to select. Select language Select language English العربية 中文 Français Русский Español Português [ World Health Organization ](https://www.who.int/ "Home") [](https://www.who.int/news/item/21-10-2026-new-who-ilo-framework-to-track-progress-towards-universal-social-protection-inclusive-of-people-with-tb) * * [ World Health Organization ](https://www.who.int/) [Global](https://www.who.int/) * [Regions](https://www.who.int/news/item/21-10-2026-new-who-ilo-framework-to-track-progress-towards-universal-social-protection-inclusive-of-people-with-tb) World Health Organization WHO Regional websites * [ Africa ](https://www.afro.who.int/) * [ Americas ](https://www.paho.org/en) * [ South-East Asia ](https://www.who.int/southeastasia) * [ Europe ](https://www.who.int/europe/) * [ Eastern Mediterranean ](http://www.emro.who.int/index.html) * [ Western Pacific ](https://www.who.int/westernpacific/) * Select language English العربية 中文 Français Русский Español Português * [HomeWorld Health Organization](https://www.who.int/) * [](https://www.who.int/news/item/21-10-2026-new-who-ilo-framework-to-track-progress-towards-universal-social-protection-inclusive-of-people-with-tb)[Health Topics](https://www.who.int/mega-menu/health-topics) * [](https://www.who.int/news/item/21-10-2026-new-who-ilo-framework-to-track-progress-towards-universal-social-protection-inclusive-of-people-with-tb)[All topics](https://www.who.int/health-topics/) * [All topics](https://www.who.int/health-topics/) * [A](https://www.who.int/health-topics/#A) * [B](https://www.who.int/health-topics/#B) * [C](https://www.who.int/health-topics/#C) * [D](https://www.who.int/health-topics/#D) * [E](https://www.who.int/health-topics/#E) * [F](https://www.who.int/health-topics/#F) * [G](https://www.who.int/health-topics/#G) * [H](https://www.who.int/health-topics/#H) * [I](https://www.who.int/health-topics/#I) * [J](https://www.who.int/health-topics/#J) * [K](https://www.who.int/health-topics/#K) * [L](https://www.who.int/health-topics/#L) * [M](https://www.who.int/health-topics/#M) * [N](https://www.who.int/health-topics/#N) * [O](https://www.who.int/health-topics/#O) * [P](https://www.who.int/health-topics/#P) * [Q](https://www.who.int/health-topics/#Q) * [R](https://www.who.int/health-topics/#R) * [S](https://www.who.int/health-topics/#S) * [T](https://www.who.int/health-topics/#T) * [U](https://www.who.int/health-topics/#U) * [V](https://www.who.int/health-topics/#V) * [W](https://www.who.int/health-topics/#W) * [X](https://www.who.int/health-topics/#X) * [Y](https://www.who.int/health-topics/#Y) * [Z](https://www.who.int/health-topics/#Z) * [ ](https://www.who.int/news/item/21-10-2026-new-who-ilo-framework-to-track-progress-towards-universal-social-protection-inclusive-of-people-with-tb)[Resources](https://www.who.int/mega-menu/health-topics/resources) * [Fact sheets](https://www.who.int/mega-menu/health-topics/resources/fact-sheets) * [Facts in pictures](https://www.who.int/mega-menu/health-topics/resources/facts-in-pictures) * [Multimedia](https://www.who.int/mega-menu/health-topics/resources/multimedia) * [Podcasts](https://www.who.int/mega-menu/health-topics/resources/podcasts) * [Publications](https://www.who.int/mega-menu/health-topics/resources/publications) * [Questions and answers](https://www.who.int/mega-menu/health-topics/resources/questions-and-answers) * [Tools and toolkits](https://www.who.int/mega-menu/health-topics/resources/tools-and-toolkits) * [ ](https://www.who.int/news/item/21-10-2026-new-who-ilo-framework-to-track-progress-towards-universal-social-protection-inclusive-of-people-with-tb)[Popular](https://www.who.int/mega-menu/health-topics/popular) * [Dengue](https://www.who.int/mega-menu/health-topics/popular/dengue) * [Endometriosis](https://www.who.int/mega-menu/health-topics/popular/endometriosis) * [Excessive heat](https://www.who.int/mega-menu/health-topics/popular/excessive-heat) * [Herpes](https://www.who.int/mega-menu/health-topics/popular/herpes) * [Mental disorders](https://www.who.int/mega-menu/health-topics/popular/mental-disorders) * [Mpox](https://www.who.int/mega-menu/health-topics/popular/mpox) * [](https://www.who.int/news/item/21-10-2026-new-who-ilo-framework-to-track-progress-towards-universal-social-protection-inclusive-of-people-with-tb)[Countries](https://www.who.int/mega-menu/countries) * [](https://www.who.int/news/item/21-10-2026-new-who-ilo-framework-to-track-progress-towards-universal-social-protection-inclusive-of-people-with-tb)[All countries](https://www.who.int/countries) * [All countries](https://www.who.int/countries) * [A](https://www.who.int/countries/#A) * [B](https://www.who.int/countries/#B) * [C](https://www.who.int/countries/#C) * [D](https://www.who.int/countries/#D) * [E](https://www.who.int/countries/#E) * [F](https://www.who.int/countries/#F) * [G](https://www.who.int/countries/#G) * [H](https://www.who.int/countries/#H) * [I](https://www.who.int/countries/#I) * [J](https://www.who.int/countries/#J) * [K](https://www.who.int/countries/#K) * [L](https://www.who.int/countries/#L) * [M](https://www.who.int/countries/#M) * [N](https://www.who.int/countries/#N) * [O](https://www.who.int/countries/#O) * [P](https://www.who.int/countries/#P) * [Q](https://www.who.int/countries/#Q) * [R](https://www.who.int/countries/#R) * [S](https://www.who.int/countries/#S) * [T](https://www.who.int/countries/#T) * [U](https://www.who.int/countries/#U) * [V](https://www.who.int/countries/#V) * [W](https://www.who.int/countries/#W) * [X](https://www.who.int/countries/#X) * [Y](https://www.who.int/countries/#Y) * [Z](https://www.who.int/countries/#Z) * [ ](https://www.who.int/news/item/21-10-2026-new-who-ilo-framework-to-track-progress-towards-universal-social-protection-inclusive-of-people-with-tb)[Regions](https://www.who.int/mega-menu/countries/regions) * [Africa](https://www.who.int/mega-menu/countries/regions/africa) * [Americas](https://www.who.int/mega-menu/countries/regions/americas) * [Europe](https://www.who.int/mega-menu/countries/regions/europe) * [Eastern Mediterranean](https://www.who.int/mega-menu/countries/regions/eastern-mediterranean) * [South-East Asia ](https://www.who.int/mega-menu/countries/regions/south-east-asia) * [Western Pacific](https://www.who.int/mega-menu/countries/regions/western-pacific) * [ ](https://www.who.int/news/item/21-10-2026-new-who-ilo-framework-to-track-progress-towards-universal-social-protection-inclusive-of-people-with-tb)[WHO in countries](https://www.who.int/mega-menu/countries/who-in-countries) * [Data by country](https://www.who.int/mega-menu/countries/who-in-countries/data-by-country) * [Country presence ](https://www.who.int/mega-menu/countries/who-in-countries/country-presence) * [Country cooperation strategies ](https://www.who.int/mega-menu/countries/who-in-countries/country-cooperation-strategies) * [Country office profiles](https://www.who.int/mega-menu/countries/who-in-countries/country-office-profiles) * [Strengthening country offices ](https://www.who.int/mega-menu/countries/who-in-countries/country-strengthening) * [](https://www.who.int/news/item/21-10-2026-new-who-ilo-framework-to-track-progress-towards-universal-social-protection-inclusive-of-people-with-tb)[Newsroom](https://www.who.int/news-room) * [ ](https://www.who.int/news/item/21-10-2026-new-who-ilo-framework-to-track-progress-towards-universal-social-protection-inclusive-of-people-with-tb)[Newsroom](https://www.who.int/mega-menu/news/all-news) * [News releases](https://www.who.int/mega-menu/news/all-news/releases) * [Statements](https://www.who.int/mega-menu/news/all-news/statements) * [Campaigns](https://www.who.int/mega-menu/news/all-news/campaigns) * [Events](https://www.who.int/mega-menu/news/all-news/events) * [Feature stories](https://www.who.int/mega-menu/news/all-news/feature-stories) * [Speeches](https://www.who.int/mega-menu/news/all-news/speecheshub) * [Commentaries](https://www.who.int/mega-menu/news/all-news/commentaries) * [Photo library](https://www.who.int/mega-menu/news/all-news/photo-library) * [Headlines](https://www.who.int/news-room/headlines) * [](https://www.who.int/news/item/21-10-2026-new-who-ilo-framework-to-track-progress-towards-universal-social-protection-inclusive-of-people-with-tb)[Emergencies](https://www.who.int/mega-menu/emergencies) * [ ](https://www.who.int/news/item/21-10-2026-new-who-ilo-framework-to-track-progress-towards-universal-social-protection-inclusive-of-people-with-tb)[In focus](https://www.who.int/mega-menu/emergencies/emergencies) * [Cholera ](https://www.who.int/mega-menu/emergencies/emergencies/cholera) * [Ebola disease](https://www.who.int/mega-menu/emergencies/emergencies/ebola-disease) * [Israel and the occupied Palestinian territory](https://www.who.int/mega-menu/emergencies/emergencies/israel-and-occupied-palestinian-territory) * [Middle East](https://www.who.int/mega-menu/emergencies/emergencies/middle-east) * [Sudan](https://www.who.int/mega-menu/emergencies/emergencies/sudan) * [Ukraine](https://www.who.int/mega-menu/emergencies/emergencies/ukraine-emergency) * [ ](https://www.who.int/news/item/21-10-2026-new-who-ilo-framework-to-track-progress-towards-universal-social-protection-inclusive-of-people-with-tb)[Latest](https://www.who.int/mega-menu/emergencies/news) * [Disease Outbreak News](https://www.who.int/mega-menu/emergencies/news/disease-outbreak-news) * [Situation reports](https://www.who.int/mega-menu/emergencies/news/situation-reports) * [Rapid risk assessments](https://www.who.int/mega-menu/emergencies/news/rapid-risk-assessment) * [Weekly Epidemiological Record](https://www.who.int/mega-menu/emergencies/news/weekly-epidemiological-record) * [ ](https://www.who.int/news/item/21-10-2026-new-who-ilo-framework-to-track-progress-towards-universal-social-protection-inclusive-of-people-with-tb)[WHO in emergencies](https://www.who.int/mega-menu/emergencies/who-in-emergencies) * [Surveillance](https://www.who.int/mega-menu/emergencies/who-in-emergencies/surveillance) * [Alert and response](https://www.who.int/mega-menu/emergencies/who-in-emergencies/alert-and-response) * [Operations](https://www.who.int/mega-menu/emergencies/who-in-emergencies/operations) * [Research](https://www.who.int/mega-menu/emergencies/who-in-emergencies/research-development) * [Funding](https://www.who.int/mega-menu/emergencies/who-in-emergencies/funding) * [Partners](https://www.who.int/mega-menu/emergencies/who-in-emergencies/partners) * [Health emergency appeals](https://www.who.int/mega-menu/emergencies/who-in-emergencies/health-emergency-appeal) * [International Health Regulations](https://www.who.int/mega-menu/emergencies/who-in-emergencies/international-health-regulations) * [Independent Oversight and Advisory Committee](https://www.who.int/mega-menu/emergencies/who-in-emergencies/independent-oversight-and-advisory-committee) * [](https://www.who.int/news/item/21-10-2026-new-who-ilo-framework-to-track-progress-towards-universal-social-protection-inclusive-of-people-with-tb)[Data](https://www.who.int/mega-menu/data) * [ ](https://www.who.int/news/item/21-10-2026-new-who-ilo-framework-to-track-progress-towards-universal-social-protection-inclusive-of-people-with-tb)[Data at WHO](https://www.who.int/mega-menu/data/data-who) * [Data hub](https://www.who.int/mega-menu/data/data-who/data-hub) * [Global Health Estimates](https://www.who.int/mega-menu/data/data-who/global-health-estimates) * [Health inequality](https://www.who.int/mega-menu/data/data-who/health-inequality) * [Global Health Observatory](https://www.who.int/mega-menu/data/data-who/global-health-obsevatory) * [ ](https://www.who.int/news/item/21-10-2026-new-who-ilo-framework-to-track-progress-towards-universal-social-protection-inclusive-of-people-with-tb)[Dashboards](https://www.who.int/mega-menu/data/dashboards) * [Triple Billion Progress](https://www.who.int/mega-menu/data/dashboards/triple-billion-progress) * [Health Inequality Monitor](https://www.who.int/mega-menu/data/dashboards/health-inequality-monitor) * [Delivery for impact](https://www.who.int/mega-menu/data/dashboards/delivery-for-impact) * [COVID-19 dashboard](https://www.who.int/mega-menu/data/dashboards/covid-19-dashboard) * [ ](https://www.who.int/news/item/21-10-2026-new-who-ilo-framework-to-track-progress-towards-universal-social-protection-inclusive-of-people-with-tb)[Data collection](https://www.who.int/mega-menu/data/data-collection) * [Classifications](https://www.who.int/mega-menu/data/data-collection/classifications) * [SCORE](https://www.who.int/mega-menu/data/data-collection/score) * [Surveys](https://www.who.int/mega-menu/data/data-collection/surveys) * [Civil registration and vital statistics](https://www.who.int/mega-menu/data/data-collection/civil-registration-and-vital-statistics) * [Routine health information systems](https://www.who.int/mega-menu/data/data-collection/routine-health-information-systems) * [Harmonized health facility assessment](https://www.who.int/mega-menu/data/data-collection/harmonized-health-facility-assessment) * [GIS centre for health](https://www.who.int/mega-menu/data/data-collection/gis-centre-for-health) * [ ](https://www.who.int/news/item/21-10-2026-new-who-ilo-framework-to-track-progress-towards-universal-social-protection-inclusive-of-people-with-tb)[Reports](https://www.who.int/mega-menu/data/reports) * [World Health Statistics](https://www.who.int/mega-menu/data/reports/world-health-statistics) * [UHC global monitoring report](https://www.who.int/mega-menu/data/reports/uhc-global-monitoring-report) * [](https://www.who.int/news/item/21-10-2026-new-who-ilo-framework-to-track-progress-towards-universal-social-protection-inclusive-of-people-with-tb)[About WHO](https://www.who.int/mega-menu/about-us) * [ ](https://www.who.int/news/item/21-10-2026-new-who-ilo-framework-to-track-progress-towards-universal-social-protection-inclusive-of-people-with-tb)[About WHO](https://www.who.int/mega-menu/about-us/about) * [Partnerships](https://www.who.int/mega-menu/about-us/about/partnerships-and-collaboration) * [Committees and advisory groups](https://www.who.int/mega-menu/about-us/about/expert-groups) * [Collaborating centres](https://www.who.int/mega-menu/about-us/about/collaborating-centres) * [Technical teams](https://www.who.int/mega-menu/about-us/about/teams) * [Organizational structure](https://www.who.int/mega-menu/about-us/about/structure) * [Who we are](https://www.who.int/mega-menu/about-us/about/who-we-are) * [ ](https://www.who.int/news/item/21-10-2026-new-who-ilo-framework-to-track-progress-towards-universal-social-protection-inclusive-of-people-with-tb)[Our work](https://www.who.int/mega-menu/about-us/our-work) * [Activities](https://www.who.int/mega-menu/about-us/our-work/activities) * [Initiatives](https://www.who.int/mega-menu/about-us/our-work/initiatives) * [General Programme of Work](https://www.who.int/mega-menu/about-us/our-work/global-programme-of-work) * [WHO Academy](https://www.who.int/mega-menu/about-us/our-work/who-academy) * [ ](https://www.who.int/news/item/21-10-2026-new-who-ilo-framework-to-track-progress-towards-universal-social-protection-inclusive-of-people-with-tb)[Funding](https://www.who.int/mega-menu/about-us/who-funding) * [Investment in WHO](https://www.who.int/mega-menu/about-us/who-funding/investment-case) * [WHO Foundation](https://www.who.int/mega-menu/about-us/who-funding/who-foundation) * [ ](https://www.who.int/news/item/21-10-2026-new-who-ilo-framework-to-track-progress-towards-universal-social-protection-inclusive-of-people-with-tb)[Accountability](https://www.who.int/mega-menu/about-us/accountability) * [External audit](https://www.who.int/mega-menu/about-us/accountability/audit) * [Financial statements](https://www.who.int/mega-menu/about-us/accountability/financial-statements) * [Internal audit and investigations ](https://www.who.int/mega-menu/about-us/accountability/internal-audit-and-investigations) * [Programme Budget](https://www.who.int/mega-menu/about-us/accountability/budget) * [Results reports](https://www.who.int/mega-menu/about-us/accountability/results-report) * [ ](https://www.who.int/news/item/21-10-2026-new-who-ilo-framework-to-track-progress-towards-universal-social-protection-inclusive-of-people-with-tb)[Governance](https://www.who.int/mega-menu/about-us/governance) * [Governing bodies](https://www.who.int/mega-menu/about-us/governance/governing-bodies-website) * [World Health Assembly](https://www.who.int/mega-menu/about-us/governance/wha) * [Executive Board](https://www.who.int/mega-menu/about-us/governance/eb) * [Member States Portal](https://www.who.int/mega-menu/about-us/governance/member-states-portal) * [HomeWorld Health Organization](https://www.who.int/) * [Health Topics](https://www.who.int/mega-menu/health-topics) * [Countries](https://www.who.int/mega-menu/countries) * [Newsroom](https://www.who.int/news-room) * [Emergencies](https://www.who.int/mega-menu/emergencies) * [Data](https://www.who.int/mega-menu/data) * [About WHO](https://www.who.int/mega-menu/about-us) * [HomeWorld Health Organization](https://www.who.int/) * [Health Topics](https://www.who.int/mega-menu/health-topics) * [All topics](https://www.who.int/health-topics/) * [All topics](https://www.who.int/health-topics/) * [A](https://www.who.int/health-topics/#A) * [B](https://www.who.int/health-topics/#B) * [C](https://www.who.int/health-topics/#C) * [D](https://www.who.int/health-topics/#D) * [E](https://www.who.int/health-topics/#E) * [F](https://www.who.int/health-topics/#F) * [G](https://www.who.int/health-topics/#G) * [H](https://www.who.int/health-topics/#H) * [I](https://www.who.int/health-topics/#I) * [J](https://www.who.int/health-topics/#J) * [K](https://www.who.int/health-topics/#K) * [L](https://www.who.int/health-topics/#L) * [M](https://www.who.int/health-topics/#M) * [N](https://www.who.int/health-topics/#N) * [O](https://www.who.int/health-topics/#O) * [P]
## Related Clinical Research

- [Self-reported tuberculosis prevalence and vulnerability factors in six rural Indian districts](https://medichelpline.com/clinical-feed/plos-one-16-self-reported-prevalence-of-tuberculosis-and-selected-associated-vulnerability.md)
- [Mycobacterium tuberculosis genomic variants linked to delamanid and pretomanid MICs](https://medichelpline.com/clinical-feed/plos-one-18-associating-mycobacterium-tuberculosis-genomic-variants-with-minimum-inhibitory.md)
- [Causes of Hospitalization in People Living with HIV in Bogotá (2018–2024): Infectious Disease Patt](https://medichelpline.com/clinical-feed/pubmed-42814691.md) (DOI: 10.1371/journal.pone.0357788)
- [Intermediary-facilitated public–private mix increased tuberculosis notifications in Viet Nam](https://medichelpline.com/clinical-feed/plos-medicine-0-evaluation-of-the-tuberculosis-notification-impact-from-an-intermediary.md)
- [ACE2 Polymorphisms rs2285666 and rs147311723 Linked to Inflammation in COVID‑19 and TB Co‑infection](https://medichelpline.com/clinical-feed/medrxiv-21-ace2-polymorphisms-rs2285666-and-rs147311723-are-clinically-relevant-variants.md)

## Navigation
- [← Back to Infectious Disease Feed](https://medichelpline.com/clinical-feed/infectious-disease.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.